D-Wave Quantum’s $20 Million University System Sale Stirs Optimism, but Revenue Slide Spurs Analyst Revisions Ahead of June Investor Day

D-Wave reports highest-ever quarterly orders of $33M but revenue sinks 81% to $2.9M. Analysts remain bullish despite price target cuts, as cash reserves hit $588M.

A single quarter can tell two completely different stories for D-Wave Quantum. On the one hand, the company just logged its highest-ever quarterly order intake, vaulting past $33 million on the back of a $20 million system sale to Florida Atlantic University and a major enterprise license. On the other, revenue collapsed 81 percent year-over-year to just $2.9 million, missing consensus by nearly a third. The result: a split verdict from Wall Street, where most analysts keep calling the stock a buy but several have trimmed their price targets.

The net loss for the first quarter of 2026 widened to $18.4 million from $5.4 million a year earlier, dragged by operating expenses that surged 125 percent to $56.5 million. That line item included $9.1 million in one-time costs tied to the acquisition of Quantum Circuits. Still, the per-share loss of $0.05 came in narrower than analysts had expected, providing a sliver of cover for the revenue miss.

D-Wave’s cash position remains a bulwark. The company ended the quarter with $588 million in cash and marketable securities, a 93 percent increase year-over-year. That war chest, combined with $42.4 million in remaining performance obligations — essentially contracted future revenue — gives management the breathing room to execute on its long-term road map.

The order book’s strength centers on two blockbuster deals: the Quantum Annealing system sold to Florida Atlantic University for $20 million and a separate multi-million-dollar license agreement with an unnamed corporate client. Those wins pushed total bookings to a record level and lifted the backlog well above where it stood at the end of fiscal 2025. D-Wave plans to recognize revenue from two annealing systems in fiscal 2026, including what would be its first commercial customer deployment.

Analyst reactions have been a study in nuance. Evercore ISI lowered its price target to $37 from $42, Mizuho to $29 from $31, and Canaccord Genuity to $41 from $43 — yet all three maintain buy ratings. Jefferies’ Kevin Garrigan held firm at $45, and Rosenblatt Securities kept its $43 target, also with a buy. Across the Street, 13 analysts now rate the shares a buy, with zero sells or holds. The stock traded around €18.86 at last check, up roughly 4 percent on the day but still more than 50 percent off its October 2025 high. Year-to-date it has shed over 21 percent.

Beyond the immediate numbers, D-Wave is laying out a multi-year technology trajectory. The company expects to have 175 physical qubits in its next-generation architecture by the end of 2028. A longer leap targets fault-tolerant systems: by 2032, D-Wave aims to deliver 100 logical qubits. In the nearer term, management plans to book two to three annealing systems in 2026, a pace that would gradually convert the record backlog into recognized sales.

The next major test comes in a few weeks. D-Wave will present at the J.P. Morgan conference in Boston and TD Cowen in New York before hosting its first-ever Investor Day on June 1, 2026, under the banner “The D-Wave Difference.” There, executives must show how a pipeline of orders transforms into sustainable revenue — a question that has dogged the stock even as the order book swells.